You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma celebrates Primary Immunodeficiency Week

The company stands alongside PI patients associations around the globe

read more 

EVENTS

Kedrion Biopharma celebrates World Hemophilia Day 2018

Support for patients with coagulation disorders worldwide is confirmed

read more 

EVENTS

50-Year Anniversary of a Maternal Health Breakthrough

Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

read more 
  1. CORPORATE - 12-10-2015

    Kedrion supports Fondazione Paracelso's activities in Afghanistan

    Kedrion confirms its commitment to broaden access to hemophilia treatments in developing Countries

    read more 
  2. CORPORATE - 29-09-2015

    Kedrion Notes 2019 Tender Offer results

    Kedrion has accepted for purchase Notes validly tendered for a total aggregate principal amount equal to €150,716,000

    read more 
  3. CORPORATE - 21-09-2015

    Cash Tender Offer for Notes due 24 April 2019

    Kedrion S.p.A. announced Cash Tender Offer for its €300,000,000 4.625 per cent. outstanding Notes due 24 April 2019

    read more 
  4. CORPORATE - 20-07-2015

    KEDPlasma welcomes donors to its new Augsburg collection center

    Plasma collected in Germany is essential to Kedrion Biopharma’s plasma-derived therapies

    read more 

Pages

For more information please contact: pressoffice@kedrion.com